# Ajanta Pharma USA Inc – FDA Inspection, Mar 17, 2016

Source: https://www.keypedia.com/records/fda_inspections/ajanta-pharma-usa-inc/923413a9-339f-459b-b453-59bc8a5fed91
Source feed: FDA_Inspections

> FDA inspection 965140 of Ajanta Pharma USA Inc, March 17, 2016. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 314. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 965140
- Company Name: Ajanta Pharma USA Inc
- Inspection Date: 2016-03-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1276284 - 2025-07-22](https://www.keypedia.com/records/fda_inspections/ajanta-pharma-usa-inc/659b0944-41d5-43b5-a2ed-eb7d4abb5387)
- FDA Inspection 1049436 - 2018-04-04

Company: https://www.keypedia.com/companies/ajanta-pharma-usa-inc/fb94ebd3-ce80-4426-8f91-9f82716e5ea6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
